 | • レポートコード：MRC2105A016 • 出版社/出版日：Persistence Market Research / 2021年2月 • レポート形態：英文、PDF、272ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートは、世界の抗生物質耐性市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、市場分析/予測、価格分析、医薬品クラス別（βラクタム抗生物質、セファロスポリン、キノロン系抗生物質、マクロライド抗生物質、テトラサイクリン、その他）分析、病原体別（黄色ブドウ球菌、肺炎レンサ球菌、淋菌、腸球菌、大腸菌、その他）分析、疾患別（市中感染性細菌性肺炎（CABP）、院内感染細菌性肺炎・人工呼吸器（HABP・VABP）、複雑性尿路感染症（CUTI）、複雑性腹腔内感染症（CIAI）、菌血症（BSI）、その他）分析、作用機序別（細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、その他）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症の危機分析 ・市場分析/予測 ・価格分析 ・世界の抗生物質耐性市場規模：医薬品クラス別（βラクタム抗生物質、セファロスポリン、キノロン系抗生物質、マクロライド抗生物質、テトラサイクリン、その他） ・世界の抗生物質耐性市場規模：病原体別（黄色ブドウ球菌、肺炎レンサ球菌、淋菌、腸球菌、大腸菌、その他） ・世界の抗生物質耐性市場規模：疾患別（市中感染性細菌性肺炎（CABP）、院内感染細菌性肺炎・人工呼吸器（HABP・VABP）、複雑性尿路感染症（CUTI）、複雑性腹腔内感染症（CIAI）、菌血症（BSI）、その他） ・世界の抗生物質耐性市場規模：作用機序別（細胞壁合成阻害剤、タンパク質合成阻害剤、DNA合成阻害剤、RNA合成阻害剤、その他） ・世界の抗生物質耐性市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Antibiotic Resistance Market – Scope of Report
A latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the antibiotic resistance market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the antibiotic resistance market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research’s study. This research study can support readers know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the antibiotic resistance space, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the antibiotic resistance industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the antibiotic resistance market offers information divided into six important segments — drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.
Drug Class
Beta Lactam Antibiotics
Cephalosporin
Quinolones Antibiotics
Macrolide Antibiotics
Tetracycline
Oxazolidinones
Others
Pathogen
Staphylococcus aureus
Streptococcus pneumonia
Neisseria gonorrhoeae
Enterococcus faecium
Escherichia coli
Klebsiella Pneumonia
Shigella
Clostridium difficile
Others
Disease
Community Acquired Bacterial Pneumonia (CABP)
Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
Complicated Urinary Tract Infections (CUTI)
Complicated Intra-Abdominal Infections (CIAI)
Blood Stream Infections (BSI)
Abdominal Infection and Diarrhoea (Clostridium difficile infections (CDI) & Shigella)
Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Drug Resistant Gonorrhoeae
Mechanism of Action
Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Others
Distribution Channel
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
MEA
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for antibiotic resistance?
Which parameters will bring a change in the demand for antibiotic resistance products during the forecast period?
How will changing trends impact the market?
How will the COVID-19 pandemic impact market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the winning strategies of stakeholders in the antibiotic resistance market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the market?
How can businesses in the antibiotic resistance market avail the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the antibiotic resistance market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the antibiotic resistance market more accurate and reliable.
レポート目次Table 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 01: Global Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 03: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 04: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 05: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 06: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 07: Global Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Region
Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 10: North America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 13: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 14: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 17: Latin America Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 19: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 20: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 21: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 22: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 23: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 24: Europe Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 25: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 26: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 27: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 28: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 29: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 30: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 31: South Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 36: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 37: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 38: East Asia Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 39: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 40: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 41: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 42: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 43: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 44: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 45: Oceania Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 46: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 47: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 48: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 49: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel
Table 50: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, by Country
Table 51: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 52: MEA Antibiotic Resistance Market Volume (Units) Analysis 2015–2019 and Forecast 2021- 2031, By Drug Class
Table 53: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Disease
Table 54: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 55: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Mechanism of action
Table 56: MEA Antibiotic Resistance Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2021- 2031, By Distribution Channel